BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37308211)

  • 1. Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta.
    Heer E; Ruan Y; Boyne DJ; Jarada TN; Heng D; Henning JW; Morris DM; O'Sullivan DE; Cheung WY; Brenner DR
    CMAJ; 2023 Jun; 195(23):E804-E812. PubMed ID: 37308211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021.
    Tran C; Cipriano LE; Driman DK
    CMAJ Open; 2023; 11(3):E475-E484. PubMed ID: 37279981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment.
    Han X; Yang NN; Nogueira L; Jiang C; Wagle NS; Zhao J; Shi KS; Fan Q; Schafer E; Yabroff KR; Jemal A
    Lancet Oncol; 2023 Aug; 24(8):855-867. PubMed ID: 37541271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis.
    Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system.
    Greene G; Griffiths R; Han J; Akbari A; Jones M; Lyons J; Lyons RA; Rolles M; Torabi F; Warlow J; Morris ERA; Lawler M; Huws DW
    Br J Cancer; 2022 Aug; 127(3):558-568. PubMed ID: 35501391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study.
    Lee-Ying R; O'Sullivan DE; Gagnon R; Bosma N; Stewart RN; Railton C; Tilley D; Alimohamed N; Basappa N; Cheng T; Kolinsky M; Karim S; Ruether D; North S; Yip S; Danielson B; Heng D; Brenner D
    CMAJ Open; 2022; 10(3):E633-E642. PubMed ID: 35790231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in ischemic stroke presentations, management and outcomes during the first year of the COVID-19 pandemic in Alberta: a population study.
    Ganesh A; Stang JM; McAlister FA; Shlakhter O; Holodinsky JK; Mann B; Hill MD; Smith EE
    CMAJ; 2022 Mar; 194(12):E444-E455. PubMed ID: 35347047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
    Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
    Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study.
    Barclay NL; Català M; Jödicke AM; Prieto-Alhambra D; Newby D; Delmestri A; Man WY; Serrano ÀR; Moncusí MP;
    Ther Adv Med Oncol; 2024; 16():17588359241253115. PubMed ID: 38832300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced incidence of diabetes during the COVID-19 pandemic in Alberta: A time-segmented longitudinal study of Alberta's Tomorrow Project.
    Ye M; Vena JE; Shen-Tu G; Johnson JA; Eurich DT
    Diabetes Obes Metab; 2024 Apr; 26(4):1244-1251. PubMed ID: 38131246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
    de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada.
    Ramanakumar AV; Annie B; Frederic L; Christine B; Cathy R; Jean L
    Cancer Med; 2023 Mar; 12(5):6260-6269. PubMed ID: 36385491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis.
    Peacock HM; Tambuyzer T; Verdoodt F; Calay F; Poirel HA; De Schutter H; Francart J; Van Damme N; Van Eycken L
    ESMO Open; 2021 Aug; 6(4):100197. PubMed ID: 34474811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Cancer Diagnoses Before and During the COVID-19 Pandemic.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
    JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study.
    Barclay NL; Pineda Moncusí M; Jödicke AM; Prieto-Alhambra D; Raventós B; Newby D; Delmestri A; Man WY; Chen X; Català M
    Front Oncol; 2024; 14():1370862. PubMed ID: 38601756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the COVID-19 pandemic on diagnosis of new cancers: A national multicenter study of the Veterans Affairs Healthcare System.
    Englum BR; Prasad NK; Lake RE; Mayorga-Carlin M; Turner DJ; Siddiqui T; Sorkin JD; Lal BK
    Cancer; 2022 Mar; 128(5):1048-1056. PubMed ID: 34866184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between neighborhood-level income and cancer stage at diagnosis and survival in Alberta.
    Ruan Y; Heer E; Warkentin MT; Jarada TN; O'Sullivan DE; Hao D; Ezeife D; Cheung W; Brenner DR
    Cancer; 2024 Feb; 130(4):563-575. PubMed ID: 37994148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growing Deficit in New Cancer Diagnoses 2 Years Into the COVID-19 Pandemic: A National Multicenter Study.
    Englum BR; Sahoo S; Mayorga-Carlin M; Hayssen H; Siddiqui T; Turner DJ; Sorkin JD; Lal BK
    Ann Surg Oncol; 2023 Dec; 30(13):8509-8518. PubMed ID: 37695458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
    Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
    J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the COVID-19 pandemic on the mortality among patients with colorectal cancer in Hiroshima, Japan: A large cancer registry study.
    Miyamori D; Kamitani T; Yoshida S; Shigenobu Y; Ikeda K; Kikuchi Y; Kashima S; Yamamoto Y
    Cancer Med; 2023 Nov; 12(21):20554-20563. PubMed ID: 37877230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.